What are the treatment options for pterygium?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Pterygium

Surgical excision with conjunctival autografting is the recommended treatment for pterygium that threatens or affects the visual axis, causes significant astigmatism, or is cosmetically concerning. 1

Understanding Pterygium

Pterygium is a wing-shaped, fleshy, vascularized growth on the conjunctiva that can progressively grow toward the visual axis and affect vision. Unlike pinguecula (a yellowish, non-vascular lesion), pterygium often requires intervention due to its potential to affect visual function 1.

Treatment Algorithm

Conservative Management

  • For small, non-progressive pterygium with minimal symptoms:
    • Artificial tears for lubrication
    • Topical anti-inflammatory drops (e.g., indomethacin 0.1%)
    • UV protection with sunglasses

Surgical Intervention

Indications for surgery include:

  • Pterygium threatening or affecting the visual axis
  • Significant astigmatism caused by pterygium
  • Cosmetic concerns
  • Persistent irritation unresponsive to conservative measures

Surgical Techniques (in order of effectiveness)

  1. Conjunctival Autografting (preferred method)

    • Involves excision of pterygium followed by transplantation of patient's own conjunctival tissue
    • Lowest recurrence rates (5-10%)
    • Best cosmetic outcome
  2. Amniotic Membrane Grafting

    • Alternative when conjunctival tissue is limited
    • Moderate recurrence rates
  3. Bare Sclera Technique

    • Not recommended as standalone procedure
    • High recurrence rates (30-89%)

Adjunctive Therapies to Reduce Recurrence

  • Mitomycin C (MMC)

    • Applied intraoperatively (0.02% for 15-60 seconds)
    • Reduces recurrence rates significantly
    • Caution: potential for delayed complications (scleral thinning)
  • 5-Fluorouracil

    • Alternative to MMC
    • Lower risk profile but possibly less effective
  • Anti-VEGF Agents

    • Emerging adjunctive therapy
    • May reduce vascularization and recurrence
  • Beta-irradiation

    • Typically 30 Gy in three fractions within 24 hours of surgery
    • Effective but less commonly used due to specialized equipment requirements
    • Recurrence rates below 15% 2

Important Considerations

  • Recurrence Prevention: Recurrence is the most common complication after pterygium surgery, with rates varying by technique 1
  • Risk Factors: Chronic UV radiation exposure, dry/dusty environments, and ocular surface inflammation increase risk 1
  • Complications: Potential complications include diplopia due to scarring or injury to the medial rectus, corneal scarring, and infection 1
  • Postoperative Care: Typically includes topical antibiotics, corticosteroids, and regular follow-up to monitor for recurrence

Special Situations

  • Recurrent Pterygium: More aggressive with higher recurrence rates

    • Consider combination approaches (conjunctival autograft + MMC)
    • More extensive surgical planning required
  • Large Pterygium: May require more extensive grafting

    • Consider amniotic membrane if conjunctival tissue is limited

The choice of surgical technique and adjunctive therapy should be based on pterygium size, location, and risk factors for recurrence. Conjunctival autografting remains the gold standard with the lowest recurrence rates and best cosmetic outcomes 1, 3.

References

Guideline

Ocular Surface Lesions: Pinguecula and Pterygium

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The role of radiotherapy in the treatment of pterygium: a review of the literature including more than 6000 treated lesions.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2011

Research

Update on overview of pterygium and its surgical management.

Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.